READ BOBBY AND TED'S STORY CLICK ON PHOTO
READ SQUEEZY'S STORY CLICK ON PHOTO

email forum - by joining the group e-mail forum you will be in contact with Alpha patients, their families, carers and friends living throughout the UK and overseas. We are a friendly group, and between us we have a wealth of knowledge and experience to share. There is always someone to help with any worries or queries you might have.

RESEARCH

 






Astraeus, an investigational study into a potential oral treatment for Alpha-1 lung disease, is currently active and recruiting in the UK. There are seven different trial sites in England and one in Scotland.

www.astraeus-alpha1.com

 
 


 

EARCO has a global vision to increase the early diagnosis of Alpha-1 antitrypsin deficiency (AATD), understand better the natural history of the disease and ensure optimal access to effective care, placing emphasis on ambitions that serve collective needs of the AATD research community and bringing people with AAT deficiency to the centre of the research environment in a real-world context.

 

 

 

ADAPT (Antitrypsin Deficiency Assessment and Programme for Treatment) is a non NHS funded research programme and was established by researchers who have an international reputation for their research into the causes of emphysema, in collaboration with the pharmaceutical company Bayer.
ADAPT’s mission is to collect important information about how AAT deficiency affects you and your family. 

Further information can be obtained:

Mrs Rebecca Bray
ADAPT Project Co-ordinator
0121 371 3885





Thank You!

 
 

 
 

 
 
       

Fundraising